Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

GEMCITABINE-OXALIPLATIN

Placeholder slot
 (jem-SY-tuh-been-ok-SA-lih-pla-tin)

This chemotherapy combination contains the drugs gemcitabine hydrochloride and oxaliplatin. Combinations usually work better than single drugs because different drugs kill cancer cells in different ways.

Drugs in the GEMCITABINE-OXALIPLATIN combination:
Gemcitabine Hydrochloride
Oxaliplatin

Each of the drugs in this combination is approved by the Food and Drug Administration (FDA) to treat cancer or conditions related to cancer.

Use in Cancer

GEMCITABINE-OXALIPLATIN is used to treat:

This combination may also be used with other drugs or treatments or to treat other types of cancer.

More About GEMCITABINE-OXALIPLATIN

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

  • Posted:
  • Updated:
Email